菖蒲麻胆汤结合丙戊酸钠对卒中后癫痫的康复影响研究

doi:10.3760/cma.j.issn.1007-1245.2023.23.014

摘要/Abstract

摘要：

目的　观察菖蒲麻胆汤结合丙戊酸钠对卒中后癫痫患者神经及运动功能康复效果的影响。方法　本文为前瞻性研究。选取2021年1月至2022年12月南阳医学高等专科学校第一附属医院收治的121例卒中后癫痫患者为研究对象，采用随机数字表法分为对照组（60例）和联合组（61例）。对照组男32例、女28例，年龄（61.22±5.33）岁，采用丙戊酸钠治疗；联合组男31例、女30例，年龄（60.33±5.25）岁，采用菖蒲麻胆汤结合丙戊酸钠治疗。对比两组患者治疗前后癫痫发作情况，脑神经功能、运动功能改善情况及用药安全性。采用t检验、χ²检验。结果　治疗前，两组患者癫痫发作情况、脑神经功能、运动功能比较，差异均无统计学意义（均P>0.05）。治疗后，联合组癫痫发作次数［（2.15±0.27）次/月］低于对照组［（3.31±0.42）次/月］，症状持续时间［（1.25±0.36）min/次］短于对照组（2.29±0.46）min/次］，差异均有统计学意义（t=18.102、13.862，均P<0.05）。治疗后，联合组神经元特异性烯醇化酶（NSE）［（35.25±10.61）μg/L］、神经元轴突轻链（NF-L）［（1 033.46±200.27）μg/L］均低于对照组［（42.11±10.77）μg/L、（1 192.72±200.64）μg/L］，简易精神状态检查量表（MMSE）评分［（26.11±5.15）分］高于对照组［（23.32±5.19）分］，差异均有统计学意义（t=3.560、4.370、2.968，均P<0.05）。治疗后，联合组Fugl-Meyer运动功能评分（FMA）上肢评分［（58.44±10.33）分］、下肢评分［（28.72±5.31）分］均高于对照组［（51.15±10.11）分、（25.21±5.28）分］，差异均有统计学意义（t=3.923、3.643，均P<0.05）。治疗后，联合组药物相关不良反应发生率［6.56%（4/61）］与对照组［5.00%（3/60）］比较，差异无统计学意义（χ²=0.223，P>0.05）。结论　菖蒲麻胆汤结合丙戊酸钠治疗卒中后癫痫可有效促进患者癫痫症状恢复，对改善患者脑神经功能及运动功能均有积极意义，此联合用药方法未明显增加药物不良反应发生风险，安全性较高。

关键词:

卒中后癫痫, 菖蒲麻胆汤, 丙戊酸钠, 神经功能, 运动功能

Abstract:

To observe the effect of Changpu Madan decoction combined with sodium valproate on the rehabilitation of neurological and motor function in patients with post-stroke epilepsy. Methods　This article was a prospective study. A total of 121 patients with post-stroke epilepsy in the First Affiliated Hospital of Nanyang Medical College from January 2021 to December 2022 were selected as the study objects, and were divided into a control group (60 cases) and a combination group (61 cases) by the random number table method. In the control group, 32 males and 28 females, aged (61.22±5.33) years, were treated with sodium valproate. In the combination group, 31 males and 30 females, aged (60.33±5.25) years, were treated with Changpu Madan decoction combined with sodium valproate. The seizure statuses of the two groups before and after treatment were compared, as well as improvement of brain nerve function and motor function, and medication safety. t test and χ² test were used. Results　Before treatment, there were no statistically significant differences in the seizure status, brain nerve function, and motor function between the two groups (all P>0.05).After treatment, the number of seizures [(2.15±0.27) times/month] and duration of symptoms [(1.25±0.36) min/time] in the combination group were lower than those in the control group [(3.31±0.42) times/month and (2.29±0.46) min/time], with statistically significant differences (t=18.102 and 13.862, both P<0.05). After treatment, the levels of neuron-specific enolase (NSE) [(35.25±10.61) μg/L] and neuro filament light chain (NF-L) [(1 033.46±200.27) μg/L] in the combination group were lower than those in the control group [(42.11±10.77) μg/L and (1 192.72±200.64) μg/L], while the score of Mini-Mental State Examination (MMSE) [(26.11±5.15) points] was higher than that in the control group [(23.32±5.19) points], with statistically significant differences (t=3.560, 4.370, and 2.968; all P<0.05). After treatment, the upper limb and lower limb scores of Fugl-Meyer Motor Function Assessment (FMA) in the combination group were higher than those in the control group [(58.44±10.33) points vs. (51.15±10.11) points, (28.72±5.31) points vs. (25.21±5.28) points], with statistically significant differences (t=3.923 and 3.643, both P<0.05). After treatment, there was no statistically significant difference in the incidence of drug-related adverse reactions between the combination group [6.56% (4/61)] and the control group [5.00% (3/60)] (χ²=0.223, P>0.05). Conclusions　The combination of Changpu Madan decoction and sodium valproate in the treatment of post-stroke epilepsy can effectively promote the recovery of epilepsy symptoms in patients, and has a positive significance in improving their brain nerve function and motor function. The combined medication method does not significantly increase the risk of drug-related adverse reactions, with high safety.

Key words:

Post-stroke epilepsy, Changpu Madan decoction, Sodium valproate, Neurological function, Motor function

李琳琳邓倩.

菖蒲麻胆汤结合丙戊酸钠对卒中后癫痫的康复影响研究 [J]. 国际医药卫生导报, 2023, 29(23): 3383-3387.

Li Linlin, Deng Qian.

Study on the effect of Changpu Madan decoction combined with sodium valproate on rehabilitation of post-stroke epilepsy patients [J]. International Medicine and Health Guidance News, 2023, 29(23): 3383-3387.

参考文献

[1] 路晶,赵伟. 卒中后癫痫的研究进展[J]. 河北医药,2021,43(6):931-936.DOI:10.3969/j.issn.1002-7386.2021. 06.032.
[2] Galovic M, Ferreira-Atuesta C, Abraira L, et al. Seizures and epilepsy after stroke: epidemiology, biomarkers and management[J].Drugs Aging,2021,38(4):285-299.DOI:10.1007/s40266-021-00837-7.
[3] 李亚娟,刘亮,高巧林. 丙戊酸钠治疗脑卒中后癫痫患者疗效及对凝血指标的影响[J]. 血栓与止血学,2022,28(3):754-755.DOI:10.3969/j.issn.1009-6213.2022.03.180.
[4] 李花,许济. 脑卒中后癫痫持续状态复发及其相关因素分析[J]. 中西医结合心脑血管病杂志,2021,19(22):3991-3994.DOI:10.12102/j.issn.1672-1349.2021.22.036.
[5] 房爱娟,上官鑫超,杜俊飞. 中医综合治疗脑卒中后癫痫临床观察[J]. 实用中医药杂志,2023,39(1):10-12.
[6] 高云云,杨素君,丁芳芳,等. 3D-ASL灌注成像与静息态功能MRI在癫痫诊断及鉴别中的价值[J]. 影像科学与光化学,2021,39(1):101-105.DOI:10.7517/issn.1674-0475. 200712.
[7] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 缺血性卒中基层诊疗指南(2021年)[J]. 中华全科医师杂志,2021,20(9):927-946.DOI:10.3760/cma.j.cn114798- 20210804-00590.
[8] 邓里娜,吴波. «中国脑出血诊治指南2019»更新要点及解读[J]. 心脑血管病防治,2021,21(1):13-17,34.DOI:10.3969/j.issn.1009-816x.2021.01.002.
[9] 侯宇婷,石佳琦,王洋,等. 脑卒中后痫性发作与脑卒中后癫痫的研究进展[J]. 中华神经医学杂志,2018,17(11):1185-1188.DOI:10.3760/cma.j.issn.1671-8925.2018. 11.022.
[10] Jia X, Wang Z, Huang F, et al. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study[J].BMC Psychiatry,2021,21(1):485.DOI:10.1186/s12888-021-03495-6.
[11] Song X, Chen S, Jia J, et al. Cellphone-based automated Fugl-Meyer assessment to evaluate upper extremity motor function after stroke[J].IEEE Trans Neural Syst Rehabil Eng,2019,27(10):2186-2195. DOI:10.1109/TNSRE.2019.2939587.
[12] 覃百灵,李通,胡敏婷,等. 急性缺血性卒中患者血管内治疗后早期癫痫发作的危险因素分析[J]. 中国医药导报,2022,19(21):49-52.
[13] 张鑫. 探讨缺血性脑卒中后癫痫发作的临床特点及诊疗分析[J]. 中国现代药物应用,2021,15(18):82-84.DOI:10.14164/j.cnki.cn11-5581/r.2021.18.030.
[14] 林岚,王晓燕,杨淑,等. 丙戊酸钠联合左乙拉西坦治疗脑卒中后癫痫的临床观察[J]. 中国药房,2016,27(33):4634-4637.DOI:10.6039/j.issn.1001-0408.2016.33.09.
[15] 曾晓晴,庄伟端,陈丽芬. 卒中后癫痫发作发病机制的研究进展[J]. 临床荟萃,2022,37(2):174-177.DOI:10.3969/j.issn.1004-583X.2022.02.016.
[16] 洪荣庆,李莲英,关锦贞. 中医综合治疗老年脑卒中后癫痫的疗效观察[J]. 中国临床新医学,2018,11(9):925-928.DOI:10.3969/j.issn.1674-3806.2018.09.22.
[17] 梅婷婷,闫珺,陈晶. 石菖蒲化学成分及其药理作用概述[J]. 中医药信息,2022,39(4):77-80,89.DOI:10.19656/j.cnki.1002-2406.20220415.
[18] Bagnato S, Andriolo M, Boccagni C, et al. Reduced neuron-specific enolase levels in chronic severe traumatic brain injury[J].J Neurotrauma,2020,37(2):423-427.DOI:10.1089/neu.2019.6449.
[19] Gaetani L, Blennow K, Calabresi P, et al. Neurofilament light chain as a biomarker in neurological disorders[J].J Neurol Neurosurg Psychiatry,2019,90(8):870-881.DOI:10.1136/jnnp-2018-320106.
[20] 范建岭,汪爱萍. 菖蒲麻胆汤结合阳陵泉、心肝俞等穴埋线治疗脑卒中后癫痫临床疗效及安全性探究[J]. 四川中医,2021,39(9):128-131.